Herpes zoser neuralgia
Conditions
Interventions
Group A:Group A received intravenous infusion of 5 mg dexamethasone injection daily for 5 consecutive days after admission.
Group B:Group B underwent ozone autohemotherapy once daily for 5 consecutive days after admission, with the specific method as follows: Strictly adhering to aseptic techniques, the median cubital vein
Sponsors
Nanjing Medical University Fourth Affiliated Hospital
Eligibility
Sex/Gender
All
Age
50 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. The subject voluntarily signs the informed consent for this clinical observation. 2. Age is greater than or equal to 50 years and less than or equal to 90 years, gender-neutral. 3. The time of rash appearance does not exceed 3 days. 4. The numerical pain rating scale (Numerical Rating Scale, NRS) is not less than 4 points.
Exclusion criteria
Exclusion criteria: 1. Those who do not meet the inclusion criteria, or those determined by a physician to be unsuitable for participating in this trial. 2. Allergic to ozone, dexamethasone, or acyclovir. 3. Coagulation dysfunction. 4. Suffering from malignant tumors. 5. Moderate to severe anemia. 6. Currently using immunosuppressants. 7. Presence of severe respiratory, circulatory system, or hepatic and renal insufficiency.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numerical Rating Scale score; | — |
Secondary
| Measure | Time frame |
|---|---|
| C-reactive protein;Monocyte;Lymphocyte;Monocyte ratio;Lymphocyte ratio;Hemoglobin;Erythrocyte Sedimentation Rate ;Serum albumin;Serum globulin;Interleukin-6;Blood glucose in fasting serum;Daily dosage of analgesics; | — |
Countries
China
Contacts
Public ContactCheng Zhuqiang
Nanjing Medical University Fourth Affiliated Hospital
Outcome results
None listed